Information intended for UK healthcare professionals only.
This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice. See below for full disclaimer.
This Guidelines in Practice discussed:
- knowledge of inhaler devices
- errors in inhaler use
- factors affecting drug delivery
- inhaler innovation and the Respimat®.
Dr Omar Usmani
Reader in Respiratory Medicine and Consultant Physician at the National Heart and Lung Institute (NHLI) Imperial College London and Royal Brompton Hospital (RBH)
After watching ‘The importance of inhaler choice’ webinar, download your CPD certificate here.
Feedback from live webinar attendees:
“Excellent presentation and very informative. Thank you!”
“Concise information, excellent presentation”
“Thank you for arranging this very useful webinar”
“Clear and concise session which will be very useful when assessing patients during their asthma/COPD reviews. I have never heard inhaler choice described like this but it makes perfect sense. Thank you.”
This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice. Boehringer Ingelheim Limited suggested the topic and presenter, and approved all materials related to the webinar. The sponsorship fee included an honorarium for the presenter. The views and opinions of the presenter are not necessarily those of Guidelines in Practice, its publisher, advisers, or advertisers. No part of this webinar may be reproduced in any form without the permission of the publisher.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).
Date of preparation: June 2021